Clinical Trials Arena on MSN
Astria begins Phase III long-term navenibart study for HAE
A stria Therapeutics has commenced the Phase III ORBIT-EXPANSE long-term study evaluating navenibart (STAR-0215) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback